The roles of natural triterpenoid saponins against Alzheimer's disease
暂无分享,去创建一个
Jie Zhou | K. Komatsu | C. Tohda | Xiu-Hong Piao | Xi-Tao Li | Yu Zhou | Zhi-You Yang | Yuewei Ge | Hui-Lin Li
[1] Lijuan Kou,et al. Pharmacokinetics and Oral Bioavailability of Panax Notoginseng Saponins Administered to Rats Using a Validated UPLC-MS/MS Method. , 2022, Journal of agricultural and food chemistry.
[2] Alshebli Ahmed,et al. Alzheimer’s Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms , 2022, Molecules.
[3] Jie Zhou,et al. Pharmacological effects of Eleutherococcus senticosus on the neurological disorders , 2022, Phytotherapy research : PTR.
[4] A. Ittner,et al. Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation , 2022, Science advances.
[5] Qiu Zhang,et al. Gypenoside XVII, an Active Ingredient from Gynostemma Pentaphyllum, Inhibits C3aR-Associated Synaptic Pruning in Stressed Mice , 2022, Nutrients.
[6] Qingcheng Yang,et al. Peripheral Inflammatory Biomarkers of Alzheimer's Disease. , 2022, Journal of Alzheimer's disease : JAD.
[7] Yi Zhang,et al. Xanthoceraside exerts anti-Alzheimer's disease effect by remodeling gut microbiota and modulating microbial-derived metabolites level in rats. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[8] M. Kim,et al. Cycloastragenol, a Triterpenoid Saponin, Regulates Oxidative Stress, Neurotrophic Dysfunctions, Neuroinflammation and Apoptotic Cell Death in Neurodegenerative Conditions , 2021, Cells.
[9] T. G. Singh,et al. Apoptotic Pathways and Alzheimer’s Disease: Probing Therapeutic Potential , 2021, Neurochemical Research.
[10] K. Tam,et al. Pathological mechanisms and therapeutic strategies for Alzheimer’s disease , 2021, Neural regeneration research.
[11] T. Pufe,et al. Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells , 2021, Cells.
[12] Chunfu Wu,et al. Pseudoginsenoside-F11 ameliorates okadiac acid-induced learning and memory impairment in rats via modulating protein phosphatase 2A , 2021, Mechanisms of Ageing and Development.
[13] B. Albensi,et al. Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia , 2021, International journal of molecular sciences.
[14] Garam Lee,et al. Alzheimer's disease drug development pipeline: 2021 , 2021, Alzheimer's & dementia.
[15] S. Bardien,et al. Can the interplay between autophagy and apoptosis be targeted as a novel therapy for Parkinson's disease? , 2020, Neurobiology of Aging.
[16] Chunfu Wu,et al. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer’s disease rat model , 2020, Acta Pharmacologica Sinica.
[17] T. G. Singh,et al. Navigating Alzheimer's Disease via Chronic Stress: the Role of Glucucocorticoids. , 2020, Current drug targets.
[18] Hong Yang,et al. Protective effects of tenuifolin isolated from Polygala tenuifolia Willd roots on neuronal apoptosis and learning and memory deficits in mice with Alzheimer's disease. , 2019, Food & function.
[19] Jingwei Tian,et al. A 26-week 20(S)-ginsenoside Rg3 oral toxicity study in Beagle dogs. , 2019, Regulatory toxicology and pharmacology : RTP.
[20] Haiyan Xu,et al. Xanthoceraside Could Ameliorate Alzheimer’s Disease Symptoms of Rats by Affecting the Gut Microbiota Composition and Modulating the Endogenous Metabolite Levels , 2019, Front. Pharmacol..
[21] Xiaomei Yang,et al. Ginsenoside Rg3 prevents cognitive impairment by improving mitochondrial dysfunction in the rat model of Alzheimer's disease. , 2019, Journal of agricultural and food chemistry.
[22] Daqing Zhao,et al. Ginsenoside Re Inhibits ROS/ASK-1 Dependent Mitochondrial Apoptosis Pathway and Activation of Nrf2-Antioxidant Response in Beta-Amyloid-Challenged SH-SY5Y Cells , 2019, Molecules.
[23] U. Dwivedi,et al. Plant triterpenoid saponins: biosynthesis, in vitro production, and pharmacological relevance , 2019, Protoplasma.
[24] B. Liu,et al. High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer’s disease mice , 2019, Scientific Reports.
[25] D. Spandidos,et al. Panax ginseng components and the pathogenesis of Alzheimer's disease , 2019, Molecular medicine reports.
[26] Biqiong Zhang,et al. Ginsenoside Rg1 protects against H2O2-induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in vitro , 2018, International journal of molecular medicine.
[27] R. Linhardt,et al. Akebia saponin D reverses corticosterone hypersecretion in an Alzheimer's disease rat model. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[28] Shu Liu,et al. Study on the compatibility interactions of formula Ding‐Zhi‐Xiao‐Wan based on their main components transport characteristics across Caco‐2 monolayers model , 2018, Journal of pharmaceutical and biomedical analysis.
[29] Xing Tang,et al. Biopharmaceutical characters and bioavailability improving strategies of ginsenosides. , 2018, Fitoterapia.
[30] Ping Li,et al. Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway , 2018, Theranostics.
[31] V. Shoshan-Barmatz,et al. VDAC1, mitochondrial dysfunction, and Alzheimer's disease , 2018, Pharmacological research.
[32] Huaxi Xu,et al. Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2) , 2018, Molecular Neurodegeneration.
[33] L. Tan,et al. Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies. , 2018, Current Alzheimer research.
[34] Ajay-Vikram Singh,et al. Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer’s disease? , 2018, Journal of drug targeting.
[35] Jaehwi Lee,et al. Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability , 2018, Journal of ginseng research.
[36] Yifa Zhou,et al. Ginsenoside Rg2 protects PC12 cells against β-amyloid25-35-induced apoptosis via the phosphoinositide 3-kinase/Akt pathway. , 2017, Chemico-biological interactions.
[37] Yaodong Zhang,et al. Ginsenoside Rg1 protects against neuronal degeneration induced by chronic dexamethasone treatment by inhibiting NLRP-1 inflammasomes in mice , 2017, International journal of molecular medicine.
[38] W. Fu,et al. Drug candidates in clinical trials for Alzheimer’s disease , 2017, Journal of Biomedical Science.
[39] Jian-Mei Li,et al. Aging-associated metabolic disorder induces Nox2 activation and oxidative damage of endothelial function , 2017, Free radical biology & medicine.
[40] L. Ren,et al. Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer’s Disease Through Inhibition of BACE1 , 2017, Molecular Neurobiology.
[41] Eugenia Trushina,et al. Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease , 2017, Journal of Alzheimer's disease : JAD.
[42] Hong Zhang,et al. Inhibitory Effect of Lychee Seed Saponins on Apoptosis Induced by Aβ25-35 through Regulation of the Apoptotic and NF-κB Pathways in PC12 Cells , 2017, Nutrients.
[43] V. Préat,et al. Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies , 2017, Molecules.
[44] J. Thornton,et al. Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease , 2017, PLoS genetics.
[45] Q. Mei,et al. Lychee Seed Saponins Improve Cognitive Function and Prevent Neuronal Injury via Inhibiting Neuronal Apoptosis in a Rat Model of Alzheimer’s Disease , 2017, Nutrients.
[46] Z. Shi,et al. Upstream regulators and downstream effectors of NF-κB in Alzheimer's disease , 2016, Journal of the Neurological Sciences.
[47] V. Víctor,et al. Role of ROS and RNS Sources in Physiological and Pathological Conditions , 2016, Oxidative medicine and cellular longevity.
[48] B. Xie,et al. Ameliorative effect of lotus seedpod proanthocyanidins on cognitive impairment and brain aging induced by d-galactose , 2016, Experimental Gerontology.
[49] Juliet M. Taylor,et al. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease , 2016, Journal of neurochemistry.
[50] Mary Miu Yee Waye,et al. Polygenic Analysis of Late-Onset Alzheimer’s Disease from Mainland China , 2015, PloS one.
[51] Y. Pak,et al. Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB. , 2015, Journal of ethnopharmacology.
[52] Gang Zhao,et al. Ginsenoside Rd attenuates Aβ25-35-induced oxidative stress and apoptosis in primary cultured hippocampal neurons. , 2015, Chemico-biological interactions.
[53] Sagar H. Barage,et al. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease , 2015, Neuropeptides.
[54] Y. Liu,et al. Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer's disease mouse model: a metabolomics study. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[55] R. Xu,et al. Neuroprotection by Saponins , 2015, Phytotherapy research : PTR.
[56] D. Paik,et al. Review of cases of patient risk associated with ginseng abuse and misuse , 2014, Journal of ginseng research.
[57] Luc Buée,et al. PTU‐induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments , 2014, Hippocampus.
[58] M. Obulesu,et al. Apoptosis in Alzheimer’s Disease: An Understanding of the Physiology, Pathology and Therapeutic Avenues , 2014, Neurochemical Research.
[59] O. Arancio,et al. Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation , 2014, Scientific Reports.
[60] Bing Liu,et al. Jujuboside A, a neuroprotective agent from semen Ziziphi Spinosae ameliorates behavioral disorders of the dementia mouse model induced by Aβ 1-42. , 2014, European journal of pharmacology.
[61] Guibo Sun,et al. Notoginsenoside R1 attenuates amyloid-β-induced damage in neurons by inhibiting reactive oxygen species and modulating MAPK activation. , 2014, International immunopharmacology.
[62] Y. Kitagishi,et al. Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer’s disease , 2014, Alzheimer's Research & Therapy.
[63] Guangji Wang,et al. Pharmacokinetic Compatibility of Ginsenosides and Schisandra Lignans in Shengmai-san: From the Perspective of P-Glycoprotein , 2014, PloS one.
[64] Zheying Zhang,et al. Madecassoside prevents Aβ(25-35)-induced inflammatory responses and autophagy in neuronal cells through the class III PI3K/Beclin-1/Bcl-2 pathway. , 2014, International immunopharmacology.
[65] Liang-Jun Yan,et al. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease , 2014, The International journal of neuroscience.
[66] A. Osbourn,et al. Triterpene biosynthesis in plants. , 2014, Annual review of plant biology.
[67] Zhichun Chen,et al. Oxidative stress in Alzheimer’s disease , 2014, Neuroscience Bulletin.
[68] Jin-Lan Huang,et al. Effects of Panax notoginseng saponin on &agr;, &bgr;, and &ggr; secretase involved in A&bgr; deposition in SAMP8 mice , 2014, Neuroreport.
[69] J. P. de Rivero Vaccari,et al. Pyroptotic Neuronal Cell Death Mediated by the AIM2 Inflammasome , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[70] M. Geng,et al. Synthesis and antitumor activities of naturally occurring oleanolic acid triterpenoid saponins and their derivatives. , 2013, European journal of medicinal chemistry.
[71] Chunfu Wu,et al. Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease , 2013, Pharmacology Biochemistry and Behavior.
[72] Yu Young Lee,et al. www.mdpi.com/journal/ijms Anti-Inflammatory Effect of Ginsenoside Rg5 in , 2013 .
[73] Hui-li Liu,et al. Involvement of GSK3 and PP2A in ginsenoside Rb1's attenuation of aluminum-induced tau hyperphosphorylation , 2013, Behavioural Brain Research.
[74] J. Hort,et al. Guest Editor: B. O. Popescu Blood markers of oxidative stress in Alzheimer’s disease , 2012 .
[75] K. Qin,et al. Ginsennoside Rd Attenuates Cognitive Dysfunction in a Rat Model of Alzheimer’s Disease , 2012, Neurochemical Research.
[76] Jie Xu,et al. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt. , 2012, Biochimica et biophysica acta.
[77] J. Hyun,et al. Anti-Inflammatory Mechanism of Compound K in Activated Microglia and Its Neuroprotective Effect on Experimental Stroke in Mice , 2012, Journal of Pharmacology and Experimental Therapeutics.
[78] K. Qin,et al. Protective effects of ginsenoside Rd against okadaic acid-induced neurotoxicity in vivo and in vitro. , 2011, Journal of ethnopharmacology.
[79] Taijun Yin,et al. Enhancement of Oral Bioavailability of 20(S)-Ginsenoside Rh2 through Improved Understanding of Its Absorption and Efflux Mechanisms , 2011, Drug Metabolism and Disposition.
[80] D. Praticò. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. , 2008, Trends in pharmacological sciences.
[81] N. Volkmann,et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. , 2007, Molecular cell.
[82] J. Vincken,et al. Saponins, classification and occurrence in the plant kingdom. , 2007, Phytochemistry.
[83] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[84] George Perry,et al. RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease , 1999, The Journal of Neuroscience.
[85] B. Hemmings. Akt Signaling--Linking Membrane Events to Life and Death Decisions , 1997, Science.
[86] Chunfu Wu,et al. Pseudoginsenoside‐F11 alleviates cognitive deficits and Alzheimer's disease‐type pathologies in SAMP8 mice , 2019, Pharmacological research.
[87] Feng Yang,et al. Ginsenoside Rd promotes non‐amyloidogenic pathway of amyloid precursor protein processing by regulating phosphorylation of estrogen receptor alpha , 2017, Life sciences.
[88] C. Behl,et al. Apoptosis and Alzheimer's disease , 2000, Journal of Neural Transmission.